Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion description "[These data suggest that the transcriptionally targeted hALA or oBLG driven expression of the HSVtk gene may be a feasible therapy for the treatment of human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion evidence source_evidence_literature NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion SIO_000772 10505111 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion wasDerivedFrom befree-20140225 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion wasGeneratedBy ECO_0000203 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.